ADSCaN: a randomised phase ii study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC).
Authors
Lawless, CBoyd, K
Faivre-Finn, Corinne
Fenwick, J
Haswell, T
Landau, D
Lester, J
McCartney, E
Paul, J
Shaw, A
Simoes, R
Hatton, M
Affiliation
"Institute of Cancer Sciences, University of Glasgow, Cancer ResearchIssue Date
2018-01
Metadata
Show full item recordCitation
ADSCaN: a randomised phase ii study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). 2018, 115(Suppl_1): S88 Lung CancerJournal
Lung CancerDOI
10.1016/S0169-5002(18)30224-1Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0169500218302241Type
Meetings and ProceedingsISSN
01695002ae974a485f413a2113503eed53cd6c53
10.1016/S0169-5002(18)30224-1